Close Menu

NEW YORK — Smiths Detection said on Wednesday that it has partnered with Attomarker on the development and manufacture of a SARS-CoV-2 antibody testing device.

UK-based Attomarker was spun out of the University of Exeter to develop a handheld device that works with a smartphone to rapidly measure blood biomarkers for liver disease and food allergens, as well as C-reactive protein. The company has also developed a test designed to detect immunoglobulin M, G, and A antibodies against SARS-CoV-2.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Mar
18
Sponsored by
Thermo Fisher Scientific

Viruses mutate as they strive to thrive in response to selective pressures.

Mar
29
Sponsored by
Thermo Fisher Scientific

Global genetic surveillance is vital for understanding the evolution of viral pathogens and monitoring for changes in transmissibility, virulence, disease pathology, and impact on the efficacy of diagnostic tests, therapeutics, and vaccines.